Email Updates

You are here

AVAC in the News

  • The AIDS Healthcare Foundation, which has long waged a vociferous battle against Truvada (tenofovir/emtricitabine) as pre-exposure prophylaxis (PrEP), has finally begun to offer measured support for the HIV prevention method.

    August 18, 2015
    AIDSMEDS
  • 2013 and 2014 Global Lube Access Mobilization (GLAM) grants were awarded to partners in Africa to support their efforts advocating lubricant availability and educating gay men, men who have sex with men and transgender individuals about its proper use.

    August 13, 2015
    The Body
  • According to Nobel laureate Françoise Barré-Sinoussi, AIDS research has made immense progress over the last decades, but there's still a lot to be done. She says less attention is being paid to HIV in wealthy countries.

    August 4, 2015
    DW
  • Over the past decade, the US President’s Emergency Plan for AIDS Relief — in partnership with other countries and financing mechanisms — has helped change the trajectory of the AIDS epidemic. Yet, right now, PEPFAR is operating without targets. Read why targets are necessary and how they drive action.

    August 3, 2015
    Devex
  • The new National HIV/AIDS Strategy (NHAS), now updated for 2015-2020, is focused heavily on prevention and includes a strong endorsement of PrEP as a strategic option. This article in BuzzFeed takes on six common misconceptions about PrEP and clarifies what the science really has to say about this blue pill.

    August 2, 2015
    BuzzFeed
  • In the past, there was a sense that stopping the HIV/AIDS epidemic would require some radically new biomedical intervention. The growing consensus, however, is that the tools needed to stamp out HIV already exist if they could just be used in the right way.

    July 7, 2015
    Nature
  • An experimental vaccine protected half of a batch of monkeys against a virus similar to the AIDS virus, scientists reported.

    July 2, 2015
    NBC News
  • Circumcision reduces the risk of contracting HIV, most scientists agree, but the consensus is not universal. One dissenter is Ronald Goldman, a psychologist in Boston, in the US, who wrote to The Times yesterday decrying the use of the procedure as an HIV prophylactic.

    July 1, 2015
    The Times (South Africa)
  • The hotly anticipated START trial, designed to answer whether starting HIV treatment at a high CD4 count is preferable to delaying, has been halted more than a year early due to powerful evidence supporting early treatment.

    June 1, 2015
    Poz
  • People who started taking AIDS drugs soon after they were diagnosed were healthier and had fewer side-effects than people who waited, a new study found. Researchers were so impressed by the results that they have stopped the study early and will offer the drugs to all the volunteers taking part.

    May 27, 2015
    NBC News

Pages